This event is an opportunity for any organisation involved in pharmacovigilance activities, as well as consultants, contractors and service providers, to gain insights from MHRA experts on a broad range of subjects. The event will provide an opportunity to review your current procedures and identify ways to improve your approach to ensure that you are inspection ready at all times.
Benefits of attending:
Understand how to avoid common deficiencies in inspections by learning from the experiences of others
Gain a greater understanding of pharmacovigilance requirements and MHRA expectations
Improve your organisations pharmacovigilance compliance through learning about enhanced processes
Opportunity to meet, network and share experiences with colleagues and ask questions of the MHRA pharmacovigilance inspectors.
What will be covered
An update of the implementation of the new pharmacovigilance legislation in relation to PSURs
An update on expectations and the importance of Reference Safety Information
The development of generic Risk Management Plans
Common inspection findings
Other topics to be confirmed nearer the date
Who should attend?
The event is relevant to anyone working in Pharmacovigilance across all types of organisations, including EEA Qualified Persons responsible for Pharmacovigilance (QPPVs), Consultants, Contractors, and drug safety representatives from the pharmaceutical industry and academia and representatives from regulatory affairs departments.
Benefits of attending:
Understand how to avoid common deficiencies in inspections by learning from the experiences of others
Gain a greater understanding of pharmacovigilance requirements and MHRA expectations
Improve your organisations pharmacovigilance compliance through learning about enhanced processes
Opportunity to meet, network and share experiences with colleagues and ask questions of the MHRA pharmacovigilance inspectors.
What will be covered
An update of the implementation of the new pharmacovigilance legislation in relation to PSURs
An update on expectations and the importance of Reference Safety Information
The development of generic Risk Management Plans
Common inspection findings
Other topics to be confirmed nearer the date
Who should attend?
The event is relevant to anyone working in Pharmacovigilance across all types of organisations, including EEA Qualified Persons responsible for Pharmacovigilance (QPPVs), Consultants, Contractors, and drug safety representatives from the pharmaceutical industry and academia and representatives from regulatory affairs departments.
